Lisa von Moltke

CIK: 0001808592

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (30.0%)

Position reduction

Option Exercises (M)4 (40.0%)

Derivative conversions

Awards (A)3 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ZBIO

Zenas BioPharma, Inc.

Officer

MCRB

Seres Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

ZBIO
Zenas BioPharma, Inc.
Jun 15, 2026
Award(A)
Stock Option (Right to Buy)
Direct
150K shares-
ZBIO
Zenas BioPharma, Inc.
Apr 15, 2025
Award(A)
Stock Option (Right to Buy)
Direct
400K shares-
MCRB
Seres Therapeutics, Inc.
Feb 18, 2025
Sale(S)
Direct
4.4K shares at avg. $0.81$4K
MCRB
Seres Therapeutics, Inc.
Feb 15, 2025
Exercise(M)
Direct
8.9K shares-
MCRB
Seres Therapeutics, Inc.
Feb 15, 2025
Exercise(M)
Direct
3K shares-
MCRB
Seres Therapeutics, Inc.
Feb 7, 2025
Award(A)
Stock Option (Right to Buy)
Direct
650K shares-
MCRB
Seres Therapeutics, Inc.
Nov 18, 2024
Sale(S)
Direct
977 shares at avg. $0.54$528.264
MCRB
Seres Therapeutics, Inc.
Nov 15, 2024
Exercise(M)
Direct
3K shares-
MCRB
Seres Therapeutics, Inc.
Oct 28, 2024
Sale(S)
Direct
4.3K shares at avg. $0.69$3K
MCRB
Seres Therapeutics, Inc.
Oct 27, 2024
Exercise(M)
Direct
13.7K shares-

		Type	Shares	Price		Ownership
Jun 15, 2026	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	150,000	-	-	Direct
Apr 15, 2025	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	400,000	-	-	Direct
Feb 18, 2025	MCRB Seres Therapeutics, Inc.	Sale(S)	4,416	$0.81	$3,579	Direct
Feb 15, 2025	MCRB Seres Therapeutics, Inc.	Exercise(M)	8,907	-	-	Direct
Feb 15, 2025	MCRB Seres Therapeutics, Inc.	Exercise(M)	2,969	-	-	Direct
Feb 7, 2025	MCRB Seres Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	650,000	-	-	Direct
Nov 18, 2024	MCRB Seres Therapeutics, Inc.	Sale(S)	977	$0.54	$528	Direct
Nov 15, 2024	MCRB Seres Therapeutics, Inc.	Exercise(M)	2,969	-	$0	Direct
Oct 28, 2024	MCRB Seres Therapeutics, Inc.	Sale(S)	4,334	$0.69	$2,991	Direct
Oct 27, 2024	MCRB Seres Therapeutics, Inc.	Exercise(M)	13,744	-	$0	Direct

1-10 of 10 transactions

About von Moltke Lisa

von Moltke Lisa (SEC CIK 0001808592) files insider reports with the SEC as Officer of Zenas BioPharma, Inc. (ZBIO) and Officer of Seres Therapeutics, Inc. (MCRB).

Signal8 holds 7 ownership filings by von Moltke Lisa (1 Form 3, 6 Form 4), filed between Oct 29, 2024 and Jun 17, 2026. Those filings report 10 transactions, from Oct 27, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on von Moltke Lisa's filings is in WALTHAM, MA.

Recent filings by von Moltke Lisa

Jun 15, 2026: Grant or award of ZBIO derivative securities (Form 4, code A).
Apr 15, 2025: Grant or award of ZBIO derivative securities (Form 4, code A).
Feb 18, 2025: Open-market sale of MCRB shares (Form 4, code S).
Feb 15, 2025: Option exercises of MCRB shares (2 lines, Form 4, code M).
Feb 7, 2025: Grant or award of MCRB derivative securities (Form 4, code A).

Other insiders filing for Zenas BioPharma, Inc. (ZBIO)

How to read Form 4 transaction codes